8-Methoxypsoralen
Specifications
298-81-7CAS Number
206-066-9EC Number
9-methoxyfuro[3,2-g]chromen-7-oneIUPAC Name
C12H8O4Chemical Formula
216.19 g/molMolecular Weight
methoxsalen; 8-Methoxypsoralen; 298-81-7; XANTHOTOXIN; Meladinine; Oxsoralen; 8-MOP; 9-Methoxy-7H-furo[3,2-g]chromen-7-one; Oxypsoralen; Meloxine; Puvalen; Xanthotoxine; Ammoidin; Meladinin; Uvadex; Meladoxen; Ammodin; 8-Methoxypsoralene; New-Meladinin; Geroxalen; Zanthotoxin; Puvamet; Psoralon-MOP; 9-Methoxypsoralen; Oxsoralen Ultra; 8-Methoxyfuranocoumarin; 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one; O-methylxanthotoxol; Vitpso; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-; Ultra Mop; 8-Methoxy-2',3',6,7-furocoumarin; Metoxalen; Metoxaleno; NCI-C55903; 8-methoxsalen; 8-Methoxy-4',5',6,7-furocoumarin; DTXSID8020830; NSC45923; 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone; 8-Methoxy-4',5':6,7-furocoumarin; 7H-Furo(3,2-G)(1)benzopyran-7-one, 9-methoxy-; 8-Methoxy-(furano-3'.2':6.7-coumarin); 8-Methoxy-[furano-3'.2':6.7-coumarin]; U4VJ29L7BQ; NSC-45923; 9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; CHEBI:18358; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone; DTXCID40830; SM-88 COMPONENT METHOXSALEN; Methoxa Dome; 8 Methoxypsoralen; methoxypsoralen; 8MOP; 9-methoxy-7H-furo(3,2-g)chromen-7-one; 8 MOP; Mopsoralen; Puvasoralen; Puvasoralen-8; RefChem:41982; 8-Methoxy(furano-3',2':6,7-coumarin); Methoxa-Dome; Oxsoralen-ultra; Methoxalen; Oxsoralen lotion; 8-MP; 9-methoxyfuro[3,2-g]chromen-7-one; Methoxy-8-psoralen; 8-methoxy psoralen; MFCD00005009; NSC 45923; Methoxsalen (Oxsoralen); 9-Methoxyfuro(3,2-g)chromen-7-one; CHEMBL416; 9-(methyloxy)-7H-furo[3,2-g]chromen-7-one; Proralone-mop; 9-methoxyfurano[3,2-g]chromen-2-one; Meladinin (VAN); NCGC00016418-07; CAS-298-81-7; Methoxaten; Oxoralen; ST041029; Deltapsoralen; Dltasoralen; Methoxsalene; Xanthatoxin; Methoxsalen, 8-; SMR000071170; CCRIS 2083; HSDB 2505; 8-Methoxypsoralen with ultraviolet A therapy; OXSORALEN (TN); SR-01000629727; EINECS 206-066-9; Methoxsalen plus ultraviolet radiation; UNII-U4VJ29L7BQ; BRN 0196453; Methoxsalen [USP:BAN:JAN]; 9-Methoxy-7H-furo(3,2-g)benzopyran-7-one; 8-methoxylpsoralen; Prestwick_661; Xanthotoxin,Methoxsalen; Methoxsalen (Standard); Spectrum_001023; 8-Methoxy(furano-3'.2':6.7-coumarin); METHOXSALEN [MI]; Prestwick0_000479; Prestwick1_000479; Prestwick2_000479; Prestwick3_000479; Spectrum2_001052; Spectrum3_000499; Spectrum4_000052; Spectrum5_001891; METHOXSALEN [JAN]; UVADEX (TN); Xanthotoxin (Methoxsalen); X0009; METHOXSALEN [HSDB]; METHOXSALEN [IARC]; Epitope ID:613448; Methoxsalen (JP18/USP); METHOXSALEN [VANDF]; 7H-Furo[3, 9-methoxy-; METHOXSALEN [MART.]; Oprea1_166319; SCHEMBL19168; BSPBio_000618; BSPBio_001997; KBioGR_000543; KBioSS_001503; METHOXSALEN [USP-RS]; METHOXSALEN [WHO-DD]; 5-19-06-00015 (Beilstein Handbook Reference); 8MO; MLS000062633; MLS002303011; DivK1c_000763; SPECTRUM1500400; SPBio_001004; SPBio_002557; 8-Methoxy-6,7-furanocoumarin; BPBio1_000680; MEGxp0_000095; orb1225399; orb2281208; orb3025346; Xanthotoxin, analytical standard; 8-Methoxypsoralen (Xanthotoxin); SCHEMBL29376525; ACon1_000174; GTPL12457; HMS502G05; KBio1_000763; KBio2_001503; KBio2_004071; KBio2_006639; KBio3_001497; METHOXSALEN [ORANGE BOOK]; 8-Methoxy-2',6,7-furocoumarin; 8-Methoxy-4',6,7-furocoumarin; NINDS_000763; HMS1569O20; HMS1920N05; HMS2091D20; HMS2096O20; HMS2269P03; HMS3259L13; HMS3655B05; HMS3884K16; HMS5080L07; Pharmakon1600-01500400; METHOXSALEN [USP MONOGRAPH]; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone; Tox21_110432; Tox21_201767; Tox21_302816; 8-Methoxypsoralen;Xanthotoxin;8-MOP; BDBM50041234; CCG-36366; EBC-11074; HY-30151R; NSC757114; s1952; SBB005950; STK735539; WLN: T C566 DO LVOJ BO1; 8-Methoxypsoralen, analytical standard; AKOS000277012; Tox21_110432_1; 9-Methoxy-furo[3,2-g]chromen-7-one; AC-4259; CS-1983; DB00553; DS-5159; FM08242; METHOXSALEN COMPONENT OF SM-88; NC00652; NSC-757114; SDCCGMLS-0042377.P002; IDI1_000763; 8-methoxy-2'',3'',6,7-furocoumarin; 8-methoxy-4'',5'':6,7-furocoumarin; NCGC00016418-01; NCGC00016418-02; NCGC00016418-03; NCGC00016418-04; NCGC00016418-05; NCGC00016418-06; NCGC00016418-08; NCGC00016418-09; NCGC00016418-10; NCGC00016418-11; NCGC00016418-12; NCGC00016418-14; NCGC00016418-15; NCGC00016418-22; NCGC00060938-02; NCGC00060938-03; NCGC00060938-04; NCGC00060938-05; NCGC00060938-06; NCGC00178871-01; NCGC00178871-02; NCGC00178871-03; NCGC00256435-01; NCGC00259316-01; HY-30151; NCI60_004085; SBI-0051443.P003; NS00004875; SW167762-4; 8-methoxy-[furano-3''.2'':6.7-coumarin]; 9-Methoxy-7H-furo[3,2-g]chromen-7-one #; EN300-52504; C01864; D00139; AB00052042-14; AB00052042-15; AB00052042_16; AB00052042_17; 9-METHOXY-2H-FURO[3,2-G]CHROMEN-2-ONE; AH-357/03514063; F239129; Q408570; SR-01000629727-2; SR-01000629727-4; BRD-K63430059-001-03-2; BRD-K63430059-001-06-5; BRD-K63430059-001-09-9; BRD-K63430059-001-16-4; BRD-K63430059-001-17-2; Z754918916; Methoxsalen, United States Pharmacopeia (USP) Reference Standard; 12692-94-3Synonyms
Products Containing 8-Methoxypsoralen
UVADEX 20 microgrammes/ml, solution pour la modification de la fraction sanguineMETHOXSALENE MACOPHARMA 20 microgrammes/mL, solution pour la modification de la fraction sanguineMELADININE 10 mg, compriméMELADININE 0,75 POUR CENT, solution pour application localeMELADININE 0,1 POUR CENT, solution pour application localeMethoxsalen - Solara Active Pharma SciencesMethoxsalen - Zeon Pharma Industries India Pvt LtdMethoxsalenXanthotoxinmethoxsalenmethoxsalen298-81-78-Methoxypsoralen298-81-7
Page 1 of 2
Companies Selling 8-Methoxypsoralen
HD
Hangzhou Dingyan Chem Co., LtdChinaAC
Aktin Chemicals, Inc.China
TE
THERAKOS EUROPE LIMITEDIrelandCR
Centre Régional de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU de ToulouseFrance
SA
Solara Active Pharma SciencesIndia